• There are no suggestions because the search field is empty.

PMCF: How QbD Group Helps You Master MDR Compliance from Plan to Report

person-image
Petra De Geest & Caroline Aernouts, Medical Affairs Manager & Senior Consultant RA Medical Devices at QbD Group

Discover how QbD supports MDR compliance with strategic PMCF planning, execution, and documentation, from plan to report.

Master MDR Compliance with Expert PMCF Support | QbD Group
3:39

Post-Market Clinical Follow-up (PMCF) is no longer optional. Under the EU Medical Device Regulation (MDR), it’s a mandatory part of your post-market surveillance strategy, and a critical piece of your technical documentation.

But PMCF isn’t just about executing clinical activities. It’s about producing clear, consistent, and audit-ready documentation that ties together your regulatory strategy, clinical evaluation, and post-market evidence. That’s where expert medical writing comes in.

In this blog, we explore how QbD helps medical device manufacturers meet MDR requirements with strong PMCF planning, documentation, and execution, from initial justification to final report.

 

 

PMCF Under MDR: Where Regulation Meets Documentation

PMCF is part of the broader Post-Market Surveillance (PMS) system and applies to all CE-marked medical devices, whether new or legacy. Its purpose? To proactively confirm the safety and performance of your device in real-world use, identify emerging risks or patterns of misuse, and continuously feed evidence back into your technical documentation.

Regulators expect to see:

 

  • A well-reasoned PMCF Plan (per Annex XIV), based on the clinical evaluation
  • Ongoing and justified data collection activities
  • A structured PMCF Report
  • Alignment across the CER, risk management documentation, and SSCP (if applicable)

And all of it must be supported by clear, scientifically robust documentation, compliant with MDR and relevant guidance documents.

Why Expertise Is Critical to PMCF Success

Having good data is not enough; how you present that data is just as important. At QbD Group, our medical writers specialize in MDR-compliant clinical documentation. We help you:

 

  • Translate your clinical evaluation into a justified PMCF plan
  • Draft and structure your PMCF Plan, clearly addressing gaps and regulatory expectations
  • Write your PMCF Report using real-world data supplied by the manufacturer
  • Integrate findings into your Clinical Evaluation Report (CER)
  • Maintain consistency and clarity across your technical documentation

This isn’t just templating—it’s medical writing that bridges evidence, interpretation, and regulatory logic, designed to withstand Notified Body scrutiny.

How QbD Supports PMCF: From Strategy to Submission

We offer an integrated clinical and regulatory approach to PMCF. Whether you need strategic input, documentation, or study execution, our team is ready to assist.

Our services include:

 

  • PMCF gap analysis and activity planning
  • Medical writing for PMCF plans, protocols, and reports
  • CRO support for PMCF studies and user surveys
  • Registry identification and search strategies
  • Expert writing and review of CERs and other technical documentation
  • Access to our Medical Advisory Board and MDR specialists

Together, we help you build a PMCF system that supports regulatory compliance, product improvement, and continued market success.

Conclusion: A Solid Strategy Is the Key to PMCF Compliance

Complying with MDR goes beyond ticking boxes. It requires well-executed activities and high-quality documentation that demonstrates your device’s real-world performance and safety.

At QbD Group, we combine regulatory expertise and medical writing to help you develop PMCF plans and reports that are accurate, compliant, and aligned with your clinical and commercial objectives.

Need help with your PMCF documentation? Let’s talk.
Our experts are here to support you from first draft to final submission.

 

Stay ahead in life sciences

Keeping up with the fast-paced life sciences industry doesn’t have to be overwhelming.

Our newsletter delivers the latest insights, industry updates, and expert content directly to your inbox, helping you stay informed and make smarter decisions.

Circles-banner-short

Discover more expert content

preview_image
Webinar

PMS & PMCF Compliance for Medical Devices Under EU MDR

Join our expert-led webinar series on September 9 and 23 and discover how to turn PMS & PMCF compliance into clinical and strategic advantage — with exclusive insights from a notified body.
preview_image
Case study

Multiplex Respiratory Antigen Test: Accelerating IVDR Market Access

Fast-track your IVDR market access with our expertise. We help clients navigate regulatory hurdles to launch innovative diagnostic solutions efficiently and effectively.
preview_image
Case study

Faster Market Entry Through Integrated IVDR and WHO Strategy

Accelerate your market entry with our integrated IVDR and WHO strategy, ensuring compliance while minimizing costs and sample size for diagnostic tests.
preview_image
Case study

Multiplex STI PCR Test: Supporting a Smooth IVDR Journey

Learn how we supported a global IVD manufacturer in achieving IVDR compliance for their multiplex STI PCR test, ensuring timely CE-marking and future regulatory confidence.
preview_image
Case study

Fast-Tracked Site Qualification for Clinical Trial Submission

QbD Group helped a biotech company complete 5 site qualification visits in just 3 weeks enabling a timely and compliant clinical trial submission.
preview_image
Webinar

Evidence Throughout the Lifecycle: Integrating Clinical Needs into Design & Documentation

Discover how to integrate clinical needs into medical device software design to meet MDR requirements. Watch our webinar on demand.
preview_image
Whitepaper

Clinical Evaluation for Medical Devices under MDR

This whitepaper will guide you through crucial regulatory documents pertaining to the clinical evaluation process of your medical device. Download now!
preview_image
Whitepaper

IVDR extension: what does this mean for you?

In this whitepaper, you will learn the impact of the IVDR transition extension and receive tips and strategies to navigate these regulatory changes.
preview_image
Whitepaper

State-of-the-art literature review: kick off the Clinical Evaluation of your Medical Device

This whitepaper will walk you through the steps of conducting solid systematic SOTA literature searches for your clinical evaluation. Download now.
preview_image
Whitepaper

Clinical investigations under MDR: key insights and practical experiences

This whitepaper covers clinical investigation authorization under MDR, the EU Legal Representative's role, and the MDR's impact on study conduct and post-market surveillance.
preview_image
Whitepaper

The pathway from idea to patient under MDR

This guide explains the pathway and steps needed to test your device in human subjects, aiming to get your product to market. Download now.
preview_image
Case study

CE Mark Renewal for bioXtra Products: A Success Story

Discover how Lifestream Pharma successfully renewed the CE mark for their BioXtra Dry Mouth products under the EU MDR. Learn about the challenges faced, the approach taken for compliance, and the results achieved.
preview_image
Webinar

Getting Started: Overcoming Initial Obstacles in Medical Device Software Development

Watch our webinar on demand and learn about regulatory obstacles, MDR, AI Act, and best practices for medical device software development and market entry.
preview_image
Webinar

Mastering Clinical Performance Studies under IVDR

In the evolving regulatory landscape of IVDs, demonstrating clinical performance is more crucial and challenging than ever. Discover more in this webinar on demand.
preview_image
Whitepaper

Clinical evidence for In Vitro Diagnostics under IVDR

In this whitepaper, we will guide you through the documents required for the demonstration of clinical evidence under the IVDR. Download now.
preview_image
Case study

Ensuring a smooth MDR transition for Oystershell's medical devices

The landscape of medical device regulations is constantly evolving, making it a challenge for companies to keep up. Our collaboration with Oystershell, which began in July 2023, highlights our expertise in transforming complex challenges into success stories, all with a touch of QbD Clinical magic.
preview_image
Case study

Successful clinical evaluation supports rapid CE marking of Minze Health's Uroflowmeter

QbD Clinical assisted Minze Health, a urology-focused medical devices company, in obtaining CE marking under MDR through clinical evaluation.